Webinar Date/Time: Thursday, May 25th, 2023 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
This webinar will focus on the evolution of clinical trials in recent years that stem from increased focus on precision medicine in research. The experts on this panel will discuss real-world evidence on the impact on clinical trials and how these changes affect the researchers, site operations and the patient experience. They will conclude with insights into new innovations designed to increase the accuracy of patient data, improve efficiencies in operations, and allow more time for researchers to focus on what matters most: the patient.
Register Free: https://www.appliedclinicaltrialsonline.com/act_w/precision-medicine
Event Overview:
Over the past decade, clinical trials have seen transformative changes in almost every aspect of the process, from trial design to patient recruitment. As treatments become more precise in battling specific diseases, clinical trials need to test new medicines that target more specific patient populations, with a resulting increase in research program complexity. With more precision comes a greater need for additional resources, personnel, expertise, and accurate, thorough data.
Join our experts as they examine real-world evidence in the evolution of precision in clinical trials:
Speakers:
Betsy Wagner
Design Analytics Director
IQVIA
Betsy Wagner is a seasoned clinical research professional with 15+ years of progressive site, CRO, and vendor experience. She has a deep background in clinical trial operations and patient recruitment, using traditional and tech-enabled solutions. She has overseen departmental growth in both academic and community research settings, providing a variety of experiences to inform how sites can be their best in order to facilitate more patients having access to more trials.
Joanna Hill
Director, HealthPartners Cancer Research Center
Joanna Hill has over 25 years of experience in overseeing research and clinical operations in both academic and community-based healthcare systems. Throughout her career, she’s helped impact healthcare innovation, exhibiting proven financial, regulatory, and clinical management proficiencies. She has contributed to strategic institution-wide advancements, driving for better financial and operational outcomes. She received her undergraduate degree from Indiana University and her MBA from the University of Minnesota Carlson School of Management. Joanna currently serves as the Director of HealthPartners Cancer Research Center in Minneapolis/St. Paul Minnesota.
Register Free: https://www.appliedclinicaltrialsonline.com/act_w/precision-medicine
What Can ClinOps Learn from Pre-Clinical?
August 10th 2021Dr. Hanne Bak, Senior Vice President of Preclinical Manufacturing and Process Development at Regeneron speaks about her role at the company as well as their work with monoclonal antibodies, the regulatory side of manufacturing, and more.
Tirzepatide Reduces Heart Failure Risk, Improves Physical Function in HFpEF Patients
November 18th 2024The Phase III SUMMIT trial showed that tirzepatide significantly reduces the risk of worsening heart failure events or death from cardiovascular causes, enhances physical function, and leads to weight loss and reduced inflammation in patients with heart failure with preserved ejection fraction.
Twice-Yearly Lenacapavir Injections Significantly Reduce HIV Risk, PURPOSE 2 Trial Shows
November 13th 2024Full Phase III PURPOSE 2 trial results suggest that twice-yearly lenacapavir could revolutionize HIV prevention by offering a convenient and effective long-acting option for individuals at risk of infection.